tiprankstipranks
Trending News
More News >
California Nanotechnologies Corp (TSE:CNO)
:CNO
Canadian Market

California Nanotechnologies (CNO) AI Stock Analysis

Compare
25 Followers

Top Page

TS

California Nanotechnologies

(CNO)

62Neutral
California Nanotechnologies shows strong revenue growth and operational efficiency, but profitability challenges persist due to continued net losses. High leverage presents financial risks, though cash flow generation is a positive sign for future potential. Technical indicators suggest upward momentum, but valuation remains a concern with a high P/E ratio and no dividend yield. Overall, the stock is on a positive trajectory but requires careful management of profitability and leverage to ensure sustainable growth.

California Nanotechnologies (CNO) vs. S&P 500 (SPY)

California Nanotechnologies Business Overview & Revenue Model

Company DescriptionCalifornia Nanotechnologies Corp. engages in the research, development, and production of nanocrystalline materials through grain size reduction. The company provides spark plasma/ field assisted sintering (SPS/FAST); hot pressing; sintering; diffusion bonding; hot isostatic pressing; vacuum pressureless sintering; cryogenic milling, inert gas milling, planetary ball milling, and pulverizing; and material development and testing services, including mechanical alloying, composites/non-composites, mechanical testing, sample fabrication, prototyping, scanning electron microscopy analysis, and particle size analysis. It also offers SPS starter accessory kits, SPS graphite tooling, SPS systems, tungsten carbide tooling, SPS graphite crucibles, carbon graphite foil/paper, carbon felt and yarn, and quartz glass windows; and Engemini, an SPS/FAST modeling software. It serves aerospace, defense, automotive, medical, and sports and recreation industries. The company is headquartered in Cerritos, California.
How the Company Makes MoneyCalifornia Nanotechnologies makes money primarily through providing advanced materials and processing services to various industries including aerospace, defense, and automotive. Their revenue model includes the sale of custom-developed nanostructured materials and components, as well as offering specialized research and development services aimed at improving material performance. The company also engages in strategic partnerships and collaborations with industry leaders to co-develop innovative solutions, which not only enhances their technological offerings but also expands their customer base. Contract manufacturing and consulting services for the development and implementation of nanotechnologies in client projects also contribute significantly to their earnings.

California Nanotechnologies Financial Statement Overview

Summary
California Nanotechnologies demonstrates promising revenue growth and efficiency in operations, as reflected by positive EBIT and EBITDA margins. However, the transition from operating profit to net income remains challenging, with net losses persisting. The balance sheet shows progress in financial stability, yet high leverage poses risks. Cash flow generation remains strong, indicating potential for future profitability if managed carefully. Overall, the company is on a positive trajectory but must address profitability and leverage to ensure sustainable growth.
Income Statement
70
Positive
California Nanotechnologies shows strong revenue growth over the years, with a significant jump in revenue from previous periods. The gross profit margin is healthy at 61.8% for TTM, indicating efficient cost management. However, the company is currently facing a net loss, leading to a negative net profit margin of -5.6% for TTM. EBIT and EBITDA margins stand at 28% and 10%, respectively, suggesting profitability at the operating level, but there are challenges translating this into net income.
Balance Sheet
55
Neutral
The company has a high debt-to-equity ratio, indicating a significant reliance on debt financing. However, it's important to note that equity has improved from being negative in previous years to positive in the most recent TTM, showcasing a notable financial turnaround. The equity ratio remains low at 30.5%, highlighting potential leverage risks. While there is progress in decreasing liabilities, the financial stability still faces challenges.
Cash Flow
65
Positive
Operating cash flow is strong relative to net income, showing resilience in cash generation despite net losses. The Free Cash Flow has shown positive growth, with a current free cash flow value of $489,356. However, the Free Cash Flow to Net Income ratio is not applicable due to negative net income, indicating potential volatility in cash flow management.
Breakdown
Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Income StatementTotal Revenue
3.34M1.82M1.36M1.06M1.10M
Gross Profit
2.33M669.57K514.32K439.97K523.36K
EBIT
635.26K248.51K153.14K-162.50K17.20K
EBITDA
753.02K337.91K314.81K10.77K141.12K
Net Income Common Stockholders
381.68K79.76K200.60K-161.40K-74.36K
Balance SheetCash, Cash Equivalents and Short-Term Investments
841.35K294.13K65.11K25.29K56.31K
Total Assets
2.36M1.41M1.22M587.40K864.54K
Total Debt
1.21M1.94M2.15M1.94M2.31M
Net Debt
365.59K1.65M2.09M1.92M2.25M
Total Liabilities
2.21M2.70M2.58M2.24M2.47M
Stockholders Equity
145.97K-1.29M-1.36M-1.66M-1.61M
Cash FlowFree Cash Flow
89.98K604.26K45.29K33.20K180.62K
Operating Cash Flow
104.28K717.01K54.97K33.20K180.62K
Investing Cash Flow
-14.30K-112.75K0.000.00
Financing Cash Flow
535.33K-387.83K-62.52K-149.61K

California Nanotechnologies Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.58
Price Trends
50DMA
0.73
Negative
100DMA
0.83
Negative
200DMA
0.98
Negative
Market Momentum
MACD
-0.05
Positive
RSI
40.93
Neutral
STOCH
14.21
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CNO, the sentiment is Negative. The current price of 0.58 is below the 20-day moving average (MA) of 0.72, below the 50-day MA of 0.73, and below the 200-day MA of 0.98, indicating a bearish trend. The MACD of -0.05 indicates Positive momentum. The RSI at 40.93 is Neutral, neither overbought nor oversold. The STOCH value of 14.21 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:CNO.

California Nanotechnologies Peers Comparison

Overall Rating
UnderperformOutperform
Sector (59)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
TSCNO
62
Neutral
C$27.09M86.54-20.41%125.01%-123.89%
59
Neutral
$10.73B10.11-6.65%3.02%7.41%-11.17%
TSGRA
52
Neutral
C$416.28M-10.44%12.92%-3.66%
TSAPL
50
Neutral
$2.88M13.54-2.32%142.50%-100.00%-122.17%
45
Neutral
C$82.47M-84.80%13.34%
TSPYR
44
Neutral
C$84.94M-5701.32%26.79%76.97%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:CNO
California Nanotechnologies
0.58
0.18
45.00%
AVLNF
Avalon Advanced Materials
0.02
-0.04
-66.67%
TSE:APL
Appulse
0.20
0.04
25.00%
TSE:NANO
Nano One Materials
0.74
-1.11
-60.00%
TSE:PYR
PyroGenesis Canada
0.46
-0.02
-4.17%
TSE:GRA
NanoXplore Inc
2.44
-0.18
-6.87%

California Nanotechnologies Corporate Events

California Nanotechnologies Achieves Record Revenue Amidst Expansion
Jan 15, 2025

California Nanotechnologies reported record quarterly revenue of $1,806,205, marking a 56% year-over-year increase, alongside a strong adjusted EBITDA despite increased costs from capacity expansion. The company’s net income was impacted by non-cash charges related to share purchase warrants, but it remains optimistic about long-term growth due to higher manufacturing capacity and recent investments.

California Nanotechnologies Celebrates Growth and Expansion
Jan 2, 2025

California Nanotechnologies experienced major growth in 2024, expanding its manufacturing capabilities with a new facility in Santa Ana, California, equipped with cutting-edge technology like the MSP-5 SPS system. This expansion significantly enhances their production capabilities, positioning the company as a leader in advanced materials processing.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.